Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19/miR-19b-3p/FTH1 axis
Ruonan Zhang,Ting Pan,Yu Xiang,Mingming Zhang,Han Xie,Zimao Liang,Bi Chen,Cong Xu,Jing Wang,Xingxing Huang,Qianru Zhu,Ziming Zhao,Quan Gao,Chengyong Wen,Wencheng Liu,Weirui Ma,Jiao Feng,Xueni Sun,Ting Duan,Elaine Lai-Han Leung,Tian Xie,Qibiao Wu,Xinbing Sui
DOI: https://doi.org/10.1016/j.bioactmat.2021.11.013
IF: 18.9
2022-07-01
Bioactive Materials
Abstract:Curcumenol, an effective ingredient of Wenyujin, has been reported that exerted its antitumor potential in a few cancer types. However, the effect and molecular mechanism of curcumenol in lung cancer are largely unknown. Here, we found that curcumenol induced cell death and suppressed cell proliferation in lung cancer cells. Next, we demonstrated that ferroptosis was the predominant method that contributed to curcumenol-induced cell death of lung cancer <i>in vitro</i> and <i>vivo</i> for the first time. Subsequently, using RNA sequencing, we found that the long non-coding RNA H19 (lncRNA H19) was significantly downregulated in lung cancer cells treated with curcumenol, when compared to untreated controls. Overexpression of lncRNA H19 eliminated the anticancer effect of curcumenol, while lncRNA H19 knockdown promoted ferroptosis induced by curcumenol treatment. Mechanistically, we showed that lncRNA H19 functioned as a competing endogenous RNA to bind to miR-19b-3p, thereby enhanced the transcription activity of its endogenous target, ferritin heavy chain 1 (FTH1), a marker of ferroptosis. In conclusion, our data show that the natural product curcumenol exerted its antitumor effects on lung cancer by triggering ferroptosis, and the lncRNA H19/miR-19b-3p/FTH1 axis plays an essential role in curcumenol-induced ferroptotic cell death. Therefore, our findings will hopefully provide a valuable drug for treating lung cancer patients.
engineering, biomedical,materials science, biomaterials